The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
Australian biotech company Ena Respiratory said on Monday that a nasal spray it is developing to ... flu significantly reduced the growth of the coronavirus in a recent study on animals.
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results